title: Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP.
abstract: Extracellular nucleotides regulate many cellular functions through activation of purinergic receptors in the plasma membrane. Here, we show that in hematopoietic stem cell (HSC), ATP is stored in vesicles and released in a calcium-sensitive manner. HSC expresses ATP responsive P2X receptors and in vitro pharmacological P2X antagonism restrained hematopoietic progenitors proliferation, but not myeloid differentiation. In mice suffering from chronic inflammation, HSCs were significantly expanded and their cycling activity was sensitive to treatment with the P2X antagonist periodate-oxidized 2,3-dialdehyde ATP. Our results indicate that ATP acts as an autocrine stimulus in regulating HSCs pool size.
authors.affiliation: Institute for Research in Biomedicine, Bellinzona CH-6500, Switzerland. fabio.grassi@irb.unisi.ch
authors.forename: A
authors.initials: A
authors.lastname: Casati
authors.forename: M
authors.initials: M
authors.lastname: Frascoli
authors.forename: E
authors.initials: E
authors.lastname: Traggiai
authors.forename: M
authors.initials: M
authors.lastname: Proietti
authors.forename: U
authors.initials: U
authors.lastname: Schenk
authors.forename: F
authors.initials: F
authors.lastname: Grassi
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D002453:Cell Cycle / Q000187:drug effects*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002908:Chronic Disease; D022162:Cytoplasmic Vesicles / Q000187:drug effects / Q000378:metabolism; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D007249:Inflammation / Q000473:pathology; D051379:Mice; D022423:Myeloid Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D058920:Purinergic P2X Receptor Antagonists / Q000494:pharmacology; D015398:Signal Transduction / Q000187:drug effects; D051193:Toll-Like Receptors / Q000378:metabolism
chemical_list: D058920:Purinergic P2X Receptor Antagonists; D051193:Toll-Like Receptors; D000255:Adenosine Triphosphate
references.citation: Cell. 2008 Dec 12;135(6):1118-29
references.pmid: 19062086
references.citation: Cell. 2005 Jul 1;121(7):1109-21
references.pmid: 15989959
references.citation: Nature. 2003 Oct 23;425(6960):836-41
references.pmid: 14574412
references.citation: Mol Pharmacol. 1995 Aug;48(2):178-83
references.pmid: 7544432
references.citation: Ann N Y Acad Sci. 2007 Jun;1106:41-53
references.pmid: 17332071
references.citation: J Biol Chem. 1993 Apr 15;268(11):8199-203
references.pmid: 8463330
references.citation: Nat Immunol. 2006 Jul;7(7):732-9
references.pmid: 16751774
references.citation: J Exp Med. 2001 May 7;193(9):1005-14
references.pmid: 11342585
references.citation: J Neurosci. 2008 Apr 30;28(18):4702-11
references.pmid: 18448647
references.citation: J Cardiovasc Pharmacol. 1996 Jun;27(6):872-5
references.pmid: 8761855
references.citation: Nat Rev Immunol. 2003 Jul;3(7):521-33
references.pmid: 12876555
references.citation: J Biol Chem. 2002 Nov 22;277(47):44638-50
references.pmid: 12244041
references.citation: Nature. 2003 Oct 23;425(6960):841-6
references.pmid: 14574413
references.citation: J Exp Med. 2006 Feb 20;203(2):461-71
references.pmid: 16492806
references.citation: Am J Physiol Cell Physiol. 2007 Oct;293(4):C1420-5
references.pmid: 17699635
references.citation: Proc Natl Acad Sci U S A. 2006 May 16;103(20):7655-9
references.pmid: 16682648
references.citation: J Clin Invest. 2006 Oct;116(10):2808-16
references.pmid: 17016561
references.citation: Annu Rev Physiol. 2009;71:333-59
references.pmid: 18851707
references.citation: Br J Pharmacol. 1991 May;103(1):1203-5
references.pmid: 1652343
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6465-70
references.pmid: 20308565
references.citation: Nat Med. 2009 Jun;15(6):696-700
references.pmid: 19483695
references.citation: Cell. 2000 Jan 7;100(1):157-68
references.pmid: 10647940
references.citation: Stem Cells. 2008 Jul;26(7):1778-86
references.pmid: 18483422
references.citation: Nature. 2009 Apr 16;458(7240):904-8
references.pmid: 19212321
references.citation: Blood. 2009 Feb 5;113(6):1250-6
references.pmid: 18945958
references.citation: Cell. 1997 Nov 28;91(5):661-72
references.pmid: 9393859
references.citation: Thromb Haemost. 2010 Feb;103(2):398-407
references.pmid: 20024498
references.citation: J Exp Med. 2005 Jun 6;201(11):1771-80
references.pmid: 15939792
references.citation: Science. 1996 Jul 12;273(5272):242-5
references.pmid: 8662508
references.citation: Nature. 2009 Jun 25;459(7250):1131-5
references.pmid: 19440194
references.citation: Novartis Found Symp. 2006;276:26-48; discussion 48-57, 275-81
references.pmid: 16805422
references.citation: J Neurosci. 2010 Jan 13;30(2):573-82
references.pmid: 20071520
references.citation: Sci Signal. 2010 Jan 12;3(104):re1
references.pmid: 20068232
references.citation: Physiology (Bethesda). 2005 Oct;20:349-56
references.pmid: 16174874
references.citation: Blood. 2004 May 1;103(9):3258-64
references.pmid: 14726388
references.citation: J Pharmacol Exp Ther. 2008 Feb;324(2):409-15
references.pmid: 18042830
references.citation: Neuropharmacology. 2005 Mar;48(3):461-8
references.pmid: 15721178
references.citation: J Pharmacol Exp Ther. 1990 Mar;252(3):1060-7
references.pmid: 2319458
references.citation: Immunity. 2006 Jun;24(6):801-812
references.pmid: 16782035
references.citation: Nat Med. 2004 Jan;10(1):64-71
references.pmid: 14702636
references.citation: Cell. 2004 Jul 23;118(2):149-61
references.pmid: 15260986
references.citation: J Immunol. 2003 Apr 15;170(8):3939-43
references.pmid: 12682220
references.citation: Nature. 2001 Nov 1;414(6859):105-11
references.pmid: 11689955
references.citation: Blood. 2004 Sep 15;104(6):1662-70
references.pmid: 15161674
references.citation: J Biol Chem. 2003 Jan 10;278(2):1354-62
references.pmid: 12414798
references.citation: EMBO J. 2006 Aug 9;25(15):3515-23
references.pmid: 16858398